Our future research may focus on the molecular mechanism for AOX1’s dysregulation in ccRCC and how its expression impacts the behavior and biology of cancer cells by using transgenic mouse and cell lines. This evidence concerns the gene AOX1 and nonpapillary renal cell carcinoma.